Hill-Rom Holdings, Inc. (HRC) Stake Boosted by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC raised its position in Hill-Rom Holdings, Inc. (NYSE:HRC) by 12.0% during the first quarter, Holdings Channel reports. The firm owned 58,273 shares of the medical technology company’s stock after buying an additional 6,223 shares during the period. Mutual of America Capital Management LLC’s holdings in Hill-Rom Holdings were worth $4,114,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of HRC. Franklin Resources Inc. raised its stake in shares of Hill-Rom Holdings by 6.5% in the fourth quarter. Franklin Resources Inc. now owns 1,813,800 shares of the medical technology company’s stock worth $101,827,000 after buying an additional 111,100 shares during the period. State Street Corp raised its stake in shares of Hill-Rom Holdings by 2.0% in the fourth quarter. State Street Corp now owns 1,584,380 shares of the medical technology company’s stock worth $88,941,000 after buying an additional 31,171 shares during the period. Allianz Asset Management AG raised its stake in shares of Hill-Rom Holdings by 11.3% in the fourth quarter. Allianz Asset Management AG now owns 1,259,967 shares of the medical technology company’s stock worth $70,735,000 after buying an additional 127,662 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Hill-Rom Holdings by 1.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,217,088 shares of the medical technology company’s stock worth $68,329,000 after buying an additional 15,798 shares during the period. Finally, Bank of Montreal Can raised its stake in shares of Hill-Rom Holdings by 294.3% in the first quarter. Bank of Montreal Can now owns 987,030 shares of the medical technology company’s stock worth $69,684,000 after buying an additional 736,681 shares during the period. Institutional investors own 83.53% of the company’s stock.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Hill-Rom Holdings, Inc. (NYSE:HRC) traded up 2.20% during mid-day trading on Friday, hitting $74.83. 875,333 shares of the company were exchanged. The stock has a market cap of $4.92 billion, a price-to-earnings ratio of 32.32 and a beta of 1.20. The firm has a 50 day moving average price of $72.69 and a 200 day moving average price of $63.26. Hill-Rom Holdings, Inc. has a 12 month low of $47.46 and a 12 month high of $77.37.

Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Friday, April 28th. The medical technology company reported $0.88 EPS for the quarter, beating the consensus estimate of $0.79 by $0.09. The business had revenue of $678.90 million for the quarter, compared to the consensus estimate of $654.27 million. Hill-Rom Holdings had a return on equity of 19.12% and a net margin of 5.44%. The company’s revenue was up 7.3% on a year-over-year basis. During the same period last year, the business posted $0.71 EPS. Analysts anticipate that Hill-Rom Holdings, Inc. will post $3.86 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was first published by Mideast Time and is owned by of Mideast Time. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://www.mideasttime.com/hill-rom-holdings-inc-hrc-stake-boosted-by-mutual-of-america-capital-management-llc/1708094.html.

HRC has been the topic of a number of recent research reports. Stifel Nicolaus boosted their price target on shares of Hill-Rom Holdings from $70.00 to $84.00 and gave the stock a “buy” rating in a research note on Monday, May 1st. Zacks Investment Research lowered shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, February 28th. Finally, Barclays PLC upped their target price on shares of Hill-Rom Holdings from $75.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, May 1st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Hill-Rom Holdings currently has a consensus rating of “Buy” and a consensus target price of $73.00.

In related news, SVP Alton Shader sold 15,000 shares of the firm’s stock in a transaction dated Thursday, March 16th. The stock was sold at an average price of $69.34, for a total transaction of $1,040,100.00. Following the sale, the senior vice president now directly owns 52,638 shares in the company, valued at approximately $3,649,918.92. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO John J. Greisch sold 207,987 shares of the firm’s stock in a transaction dated Tuesday, March 7th. The shares were sold at an average price of $65.86, for a total value of $13,698,023.82. Following the sale, the chief executive officer now owns 301,565 shares in the company, valued at $19,861,070.90. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

5 Day Chart for NYSE:HRC

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.